Practical Management, Emerging Evidence and Technologic Advances in Small Cell Lung Cancer
This session will discuss current evidence and emerging treatment options in the management of SCLC. An overview of SCLC will be provided including definitions, staging, epidemiology, pathology and other general considerations. Pertinent controversies in limited stage SCLC, such as the timing of radiation, commonly delivered dose fractionations and the use of prophylactic cranial irradiation will be discussed. In extensive stage SCLC, the pros and cons of consolidative thoracic radiation as well as prophylactic cranial irradiation will be highlighted. Finally, the role of emerging radiation treatments, such as hippocampal sparing prophylactic cranial irradiation and stereotactic ablative radiotherapy will be considered.
This activity is available from January 11, 2018, through 11:59 p.m. Eastern time on January 10, 2021.
This activity was originally recorded at ASTRO’s 2017 Annual Meeting, September 24-27, 2017 in San Diego, CA.
This program is designed to meet the interest of radiation oncologists, radiation physicists, radiation therapists, radiation dosimetrists and radiation oncology residents.
After this session, attendees should be able to:
- Describe the evidence for the curative, palliative and prophylactic role of radiation in small cell lung cancer.
- Define the role of advanced radiation techniques such as hippocampal-sparing prophylactic cranial irradiation and stereotactic ablative radiotherapy in small cell lung cancer.
- Alexander Louie, MD, PhD, MSc, FRCPC is employed at the London Health Sciences Center and has no financial relationships with a commercial interest.
- Mark Mishra, MD is employed at the University of Maryland and receives compensation/remuneration/funding from PCOR.
- Ben Slotman, MD, PhD is employed at VU University Medical Center, receives compensation/remuneration/funding from Varian Medical Systems, Inc. and holds leadership positions at International Stereotactic Radiosurgery Society and the American Radium Society.
- Vinai Gondi, MD is employed at Radiation Oncology Consultants, Ltd., has ownership/investment interest in Radiation Oncology Consultants, Ltd., and holds a leadership position at NRG Oncology.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.